107 related articles for article (PubMed ID: 10451493)
61. An intravital microscopic study of the hepatic microcirculation in cirrhotic mice models: relationship between fibrosis and angiogenesis.
Vanheule E; Geerts AM; Van Huysse J; Schelfhout D; Praet M; Van Vlierberghe H; De Vos M; Colle I
Int J Exp Pathol; 2008 Dec; 89(6):419-32. PubMed ID: 19134051
[TBL] [Abstract][Full Text] [Related]
62. Kupffer cell depletion associated with capillarization of liver sinusoids in carbon tetrachloride-induced rat liver cirrhosis.
Lough J; Rosenthall L; Arzoumanian A; Goresky CA
J Hepatol; 1987 Oct; 5(2):190-8. PubMed ID: 3693863
[TBL] [Abstract][Full Text] [Related]
63. The effects of hepatic fibrosis on Ito cell gene expression.
Weiner FR; Shah A; Biempica L; Zern MA; Czaja MJ
Matrix; 1992 Feb; 12(1):36-43. PubMed ID: 1560788
[TBL] [Abstract][Full Text] [Related]
64. Gadolinium Chloride Inhibits the Spontaneous Resolution of Fibrosis in CCL(4)-Induced Cirrhosis.
Chávez E; Alcantar LK; Moreno MG; Muriel P
Toxicol Mech Methods; 2006; 16(9):507-13. PubMed ID: 20020993
[TBL] [Abstract][Full Text] [Related]
65. High, but not low, dietary retinoids aggravate manifestation of rat liver fibrosis.
Vollmar B; Heckmann C; Richter S; Menger MD
J Gastroenterol Hepatol; 2002 Jul; 17(7):791-9. PubMed ID: 12121510
[TBL] [Abstract][Full Text] [Related]
66. [Morphology and function of Ito cells of the liver].
Körner T; Rath FW
Z Gesamte Inn Med; 1987 Jul; 42(13):349-54. PubMed ID: 3307188
[TBL] [Abstract][Full Text] [Related]
67. [Electron microscopic study of the reversibility of sclerotic changes in the liver].
Kalashnikova MM; Rubetskoĭ LS
Arkh Patol; 1974; 36(3):51-6. PubMed ID: 4615677
[No Abstract] [Full Text] [Related]
68. Kinetics of lipopolysaccharide clearance by Kupffer and parenchyma cells in perfused rat liver.
Bikhazi AB; Jurjus AR; Kamal MT; Al-Housseini AM; Saab RN; Jaroudi WA; Bitar KM
Comp Biochem Physiol C Toxicol Pharmacol; 2001 Aug; 129(4):339-48. PubMed ID: 11489431
[TBL] [Abstract][Full Text] [Related]
69. A morphometric analysis of the hypertrophy of experimental liver cirrhosis.
Ryoo JW; Buschmann RJ
Virchows Arch A Pathol Anat Histopathol; 1983; 400(2):173-86. PubMed ID: 6412432
[TBL] [Abstract][Full Text] [Related]
70. [Dynamic changes of Ito cells in experimental cirrhosis of rat].
Zhao JM
Zhonghua Bing Li Xue Za Zhi; 1991 Jun; 20(2):91-4. PubMed ID: 1914024
[TBL] [Abstract][Full Text] [Related]
71. Experimental biliary fibrosis correlates with increased numbers of fat-storing and Kupffer cells, and portal endotoxemia.
Grinko I; Geerts A; Wisse E
J Hepatol; 1995 Oct; 23(4):449-58. PubMed ID: 8655963
[TBL] [Abstract][Full Text] [Related]
72. Phase-contrast computed tomography: A correlation study between portal pressure and three dimensional microvasculature of ex vivo liver samples from carbon tetrachloride-induced liver fibrosis in rats.
Xuan R; Zhao X; Jian J; Hu D; Qin L; Lv W; Hu C
Microvasc Res; 2019 Sep; 125():103884. PubMed ID: 31176686
[TBL] [Abstract][Full Text] [Related]
73. Roles of oxidative stress in activation of Kupffer and Ito cells in liver fibrogenesis.
Tsukamoto H; Rippe R; Niemelä O; Lin M
J Gastroenterol Hepatol; 1995; 10 Suppl 1():S50-3. PubMed ID: 8589343
[TBL] [Abstract][Full Text] [Related]
74. Role of hepatic sinusoidal cells in hepatic injury and fibrosis in the liver.
Shiratori Y; Kawase T; Shiina S; Komatsu Y; Omata M
Gastroenterol Jpn; 1993 Mar; 28 Suppl 4():102-6; discussion 112-5. PubMed ID: 8486220
[No Abstract] [Full Text] [Related]
75. In vivo quantification of ageing changes in the rat liver from early juvenile to senescent life.
Vollmar B; Pradarutti S; Richter S; Menger MD
Liver; 2002 Aug; 22(4):330-41. PubMed ID: 12296967
[TBL] [Abstract][Full Text] [Related]
76. Novel insights into the biology and physiology of the Ito cell.
Pinzani M
Pharmacol Ther; 1995 May; 66(2):387-412. PubMed ID: 7667403
[TBL] [Abstract][Full Text] [Related]
77. Hematological Abnormalities in Cirrhosis: A Narrative Review.
Lingas EC
Cureus; 2023 May; 15(5):e39239. PubMed ID: 37337504
[TBL] [Abstract][Full Text] [Related]
78. Interaction of non‑parenchymal hepatocytes in the process of hepatic fibrosis (Review).
Cheng QN; Yang X; Wu JF; Ai WB; Ni YR
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760176
[TBL] [Abstract][Full Text] [Related]
79. Nanoparticles for the treatment of liver fibrosis.
Poilil Surendran S; George Thomas R; Moon MJ; Jeong YY
Int J Nanomedicine; 2017; 12():6997-7006. PubMed ID: 29033567
[TBL] [Abstract][Full Text] [Related]
80. Hepatic macrophages in liver fibrosis: pathogenesis and potential therapeutic targets.
Li H; You H; Fan X; Jia J
BMJ Open Gastroenterol; 2016; 3(1):e000079. PubMed ID: 27252881
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
